Trial Profile
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2017
Price :
$35
*
At a glance
- Drugs Nedaplatin (Primary)
- Indications Carcinoma; Uterine cancer
- Focus Therapeutic Use
- 01 Dec 2017 Status changed from active, no longer recruiting to completed.
- 17 Jan 2017 New trial record